Journal of Surgical Research
Volume 172, Issue 1 , Pages 123-130 , January 2012

Histologic Type Predicts Survival in Patients with Retroperitoneal Soft Tissue Sarcoma1

  • Warren Tseng, M.D.

      Affiliations

    • Department of Surgery, Division of Surgical Oncology, University of California, Davis Medical Center, Sacramento, Califronia
    • ,
  • Steve R. Martinez, M.D., M.A.S.

      Affiliations

    • Department of Surgery, Division of Surgical Oncology, University of California, Davis Medical Center, Sacramento, Califronia
    • ,
  • Robert M. Tamurian, M.D.

      Affiliations

    • Department of Orthopedic Surgery, Division of Orthopedic Oncology, University of California, Davis Medical Center, Sacramento, Califronia
    • ,
  • Dariusz Borys, M.D.

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of California, Davis Medical Center, Sacramento, Califronia
    • ,
  • Robert J. Canter, M.D.

      Affiliations

    • Department of Surgery, Division of Surgical Oncology, University of California, Davis Medical Center, Sacramento, Califronia
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Orthopedic Surgery, Division of Orthopedic Oncology, University of California, Davis Medical Center, Suite 3010, 4501 X Street, Sacramento, CA 95817.

Received 10 June 2010 ,Accepted 28 July 2010.

References 

  1. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355
  2. Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010;21:397
  3. Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: An analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007;67:158
  4. Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24
  5. Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer. 2005;104:669
  6. Canter RJ, Qin LX, Ferrone CR, et al. Why do patients with low-grade soft tissue sarcoma die?. Ann Surg Oncol. 2008;15:3550
  7. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358;discussion 370
  8. Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995;221:185
  9. van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33:234
  10. Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: A population-based analysis and critical appraisal of the AJCC staging system. Ann Surg. 2009;250:970
  11. van Dalen T, Hennipman A, Van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol. 2004;11:483
  12. Greene FL. The American Joint Committee on Cancer: Updating the strategies in cancer staging. Bull Am Coll Surg. 2002;87:13
  13. Wunder JS, Nielsen TO, Maki RG, et al. Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol. 2007;8:513
  14. Anaya DA, Lahat G, Wang X, et al. Establishing prognosis in retroperitoneal sarcoma: A new histology-based paradigm. Ann Surg Oncol. 2009;16:667
  15. Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: A multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31
  16. Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381
  17. Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: A series of surgically treated patients at a single institution. Cancer. 2008;113:1657
  18. Lahat G, Madewell JE, Anaya DA, et al. Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes. Cancer. 2009;115:1081
  19. Bilimoria KY, Stewart AK, Tomlinson JS, et al. Impact of adjuvant radiation on survival: A note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol. 2007;14:3321
  20. Alvegard TA, Berg NO. Histopathology peer review of high-grade soft tissue sarcoma: The Scandinavian Sarcoma Group experience. J Clin Oncol. 1989;7:1845
  21. Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306
  22. Coindre JM, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: A review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol. 2003;16:256
  23. de Vreeze RS, de Jong D, Tielen IH, et al. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: An immunohistochemical and molecular biological analysis. Mod Pathol. 2009;22:223

PII: S0022-4804(10)00672-4

doi: 10.1016/j.jss.2010.07.056

Journal of Surgical Research
Volume 172, Issue 1 , Pages 123-130 , January 2012

Article Tools

* Image Usage & Resolution